New FDA Requirement to Support Labeling on DDIs in the Pediatric Population Blog Post
The effects of drug-drug interactions (DDIs) could differ in the pediatric population compared to adults. The resulting changes in exposure of the victim drug, because of a DDI, at a…
The Phoenix Workflow Shortcuts Every Pharmacokineticist Needs Blog Post
Certara’s Phoenix™ Pharmacokinetic and Pharmacodynamic (PK/PD) Platform can revolutionize your pharmaceutical organization’s approach to PK/PD data management and analysis. With an intuitive user interface for collecting, managing, and storing clinical…
Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors Blog Post
Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private Equity PRINCETON, N.J.— 2022年12月8日 — Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT) today announced that Arsenal Capital…
Tips & Tricks for Data Management in Phoenix WinNonlin Blog Post
Learn some tips & tricks for the Data Wizard, a data management tool in Phoenix, a pharmacokinetic/pharmacodynamic modeling and simulation platform.
Tips to Use Phoenix WinNonlin More Efficiently Blog Post
Certara’s Phoenix™ Pharmacokinetic and Pharmacodynamic (PK/PD) Platform is the single, interoperable hub for sharing pre-clinical and clinical knowledge across your organization. With Phoenix, you can create, manage, and leverage workflows…
Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase Blog Post
Arsenal will acquire approximately 30M shares at $15 per share from funds controlled by EQT Private Equity and agrees to two-year lock-up on sale of shares PRINCETON, N.J.— November 7,…
The Role of PBPK Modeling & Simulation in Infants & Neonates Blog Post
小児向けの医薬品開発において、適切なサンプルを確保し、正確な用量を決定することは、多くの要因によって困難を伴います。Age is an important factor because a drug may act…
Using PBPK Models to Predict Effects of Hepatic Impairment & DDI in Olanzapine/Samidorphan Combination Therapy Blog Post
Olanzapine is an effective antipsychotic medication used to treat schizophrenia, a disease that affects about 1 in 300 people worldwide.1 However, side effects such as weight gain can cause patients...
Why you should select your drug formulation before starting clinical studies Blog Post
創薬企業はしばしば、ヒトでの試験を急ぐあまり、創薬プロセスを駆け足で進めてしまうことがあります。Most are so curious about their new target or molecule that they may forget that the pharmaceutical…
